{"id":"https://openalex.org/W2000380004","doi":"https://doi.org/10.1016/0378-5173(89)90174-9","title":"The effect of salts on the distribution and solubility of an acidic drug","display_name":"The effect of salts on the distribution and solubility of an acidic drug","publication_year":1989,"publication_date":"1989-02-01","ids":{"openalex":"https://openalex.org/W2000380004","doi":"https://doi.org/10.1016/0378-5173(89)90174-9","mag":"2000380004"},"language":"en","primary_location":{"id":"doi:10.1016/0378-5173(89)90174-9","doi":"https://doi.org/10.1016/0378-5173(89)90174-9","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0378-5173(89)90174-9","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111725595","display_name":"Nivedita K. Pandit","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Nivedita K. Pandit","raw_affiliation_strings":["Pharmaceutics Department, Research and Development, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT 06877 U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutics Department, Research and Development, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT 06877 U.S.A","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058519018","display_name":"Jill M. Strykowski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jill M. Strykowski","raw_affiliation_strings":["Pharmaceutics Department, Research and Development, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT 06877 U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutics Department, Research and Development, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT 06877 U.S.A","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033289147","display_name":"Liudoslava V. Shtohryn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Liudoslava Shtohryn","raw_affiliation_strings":["Pharmaceutics Department, Research and Development, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT 06877 U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutics Department, Research and Development, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT 06877 U.S.A","institution_ids":["https://openalex.org/I4210160255"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5111725595"],"corresponding_institution_ids":["https://openalex.org/I4210160255"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":0.4654,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.50476796,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"50","issue":"1","first_page":"7","last_page":"13"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.5259000062942505,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.5259000062942505,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11936","display_name":"Chemical and Physical Properties in Aqueous Solutions","score":0.18690000474452972,"subfield":{"id":"https://openalex.org/subfields/1506","display_name":"Filtration and Separation"},"field":{"id":"https://openalex.org/fields/15","display_name":"Chemical Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","score":0.1615000069141388,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/salt","display_name":"salt","score":0.6439999938011169},{"id":"https://openalex.org/keywords/distribution-coefficient","display_name":"distribution coefficient","score":0.7409999966621399},{"id":"https://openalex.org/keywords/drug-solubility","display_name":"drug solubility","score":0.9150000214576721},{"id":"https://openalex.org/keywords/ion-pairing","display_name":"ion pairing","score":0.8259999752044678},{"id":"https://openalex.org/keywords/complex-formation","display_name":"complex formation","score":0.9169999957084656},{"id":"https://openalex.org/keywords/sodium-ions","display_name":"sodium ions","score":0.6570000052452087},{"id":"https://openalex.org/keywords/potassium-ions","display_name":"potassium ions","score":1.0},{"id":"https://openalex.org/keywords/calcium-ions","display_name":"calcium ions","score":1.0},{"id":"https://openalex.org/keywords/electrolyte-effects","display_name":"electrolyte effects","score":0.6990000009536743},{"id":"https://openalex.org/keywords/activity-coefficients","display_name":"activity coefficients","score":0.6980000138282776},{"id":"https://openalex.org/keywords/acidic-drugs","display_name":"acidic drugs","score":0.6119999885559082}],"concepts":[{"id":"https://openalex.org/C155574463","wikidata":"https://www.wikidata.org/wiki/Q170731","display_name":"Solubility","level":2,"score":0.9020063877105713},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7877051830291748},{"id":"https://openalex.org/C68801617","wikidata":"https://www.wikidata.org/wiki/Q162908","display_name":"Electrolyte","level":3,"score":0.6735557913780212},{"id":"https://openalex.org/C517785266","wikidata":"https://www.wikidata.org/wiki/Q703","display_name":"Potassium","level":2,"score":0.6542611718177795},{"id":"https://openalex.org/C170961132","wikidata":"https://www.wikidata.org/wiki/Q745224","display_name":"Activity coefficient","level":3,"score":0.5608629584312439},{"id":"https://openalex.org/C179104552","wikidata":"https://www.wikidata.org/wiki/Q11165","display_name":"Inorganic chemistry","level":1,"score":0.5311340689659119},{"id":"https://openalex.org/C537181965","wikidata":"https://www.wikidata.org/wiki/Q658","display_name":"Sodium","level":2,"score":0.5092955827713013},{"id":"https://openalex.org/C192552737","wikidata":"https://www.wikidata.org/wiki/Q898797","display_name":"Partition coefficient","level":2,"score":0.47504380345344543},{"id":"https://openalex.org/C145148216","wikidata":"https://www.wikidata.org/wiki/Q36496","display_name":"Ion","level":2,"score":0.4705776572227478},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.43977320194244385},{"id":"https://openalex.org/C110121322","wikidata":"https://www.wikidata.org/wiki/Q865811","display_name":"Distribution (mathematics)","level":2,"score":0.42161762714385986},{"id":"https://openalex.org/C184651966","wikidata":"https://www.wikidata.org/wiki/Q906356","display_name":"Aqueous solution","level":2,"score":0.2839929461479187},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.27292269468307495},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.21285614371299744},{"id":"https://openalex.org/C147789679","wikidata":"https://www.wikidata.org/wiki/Q11372","display_name":"Physical chemistry","level":1,"score":0.09645026922225952},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C17525397","wikidata":"https://www.wikidata.org/wiki/Q176140","display_name":"Electrode","level":2,"score":0.0},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/0378-5173(89)90174-9","doi":"https://doi.org/10.1016/0378-5173(89)90174-9","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0378-5173(89)90174-9","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W82628988","https://openalex.org/W116292138","https://openalex.org/W571894696","https://openalex.org/W1985302668","https://openalex.org/W1990301014","https://openalex.org/W2001152550","https://openalex.org/W2015142055","https://openalex.org/W2023993071","https://openalex.org/W2030813011","https://openalex.org/W2039314240","https://openalex.org/W2039812304","https://openalex.org/W2040326969","https://openalex.org/W2055196825","https://openalex.org/W2057188775","https://openalex.org/W2096542733","https://openalex.org/W2156094555","https://openalex.org/W2492101850"],"related_works":["https://openalex.org/W4415148414","https://openalex.org/W2409069178","https://openalex.org/W2075345313","https://openalex.org/W2087909593","https://openalex.org/W92774027","https://openalex.org/W2166953642","https://openalex.org/W2023479175","https://openalex.org/W2280640524","https://openalex.org/W2039812304","https://openalex.org/W2952528349"],"abstract_inverted_index":null,"counts_by_year":[{"year":2018,"cited_by_count":2},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-06-24T00:00:00"}